Trial Details

COMPLETED
Basic Information
Clinical ID c1549
Identifier NCT05844592
Trial Title First in Human, Single Ascending Dose Study
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: INV-101
Participant Information
Sponsor Innovo Therapeutics, Inc.
City Seoul
Country/Region Korea, Republic of
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2022-04-21
Primary Completion Date 2022-07-16
Completion Date 2022-08-31